| 000 | 01616 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513045508.0 | ||
| 264 | 0 | _c19950316 | |
| 008 | 199503s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBrisseau, G F | |
| 245 | 0 | 0 |
_aPosttranscriptional regulation of macrophage tissue factor expression by antioxidants. _h[electronic resource] |
| 260 |
_bBlood _cFeb 1995 |
||
| 300 |
_a1025-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAcetylcysteine _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntioxidants _xpharmacology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
| 650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLipopolysaccharides _xpharmacology |
| 650 | 0 | 4 |
_aMacrophages, Peritoneal _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xmetabolism |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 |
_aRNA Processing, Post-Transcriptional _xdrug effects |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 |
_aThiocarbamates _xpharmacology |
| 650 | 0 | 4 |
_aThromboplastin _xbiosynthesis |
| 650 | 0 | 4 |
_aTranscription Factor AP-1 _xmetabolism |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 700 | 1 | _aDackiw, A P | |
| 700 | 1 | _aCheung, P Y | |
| 700 | 1 | _aChristie, N | |
| 700 | 1 | _aRotstein, O D | |
| 773 | 0 |
_tBlood _gvol. 85 _gno. 4 _gp. 1025-35 |
|
| 999 |
_c7848628 _d7848628 |
||